IPOs: Still the Exit Strategy of Choice?
By Business Review Editor
Pharma Deals Review: Vol 2006 Issue 72 (Table of Contents)
Published: 6 Jun-2006
DOI: 10.3833/pdr.v2006.i72.507 ISSN: 1756-7874
Section: General
Fulltext:
Abstract
Launching an IPO is a huge and costly commitment in terms of both time and money...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018